Skip to content
buyWeak

John W. Higuchi bought $55k of LPCN

director at Lipocine Inc.. 25,007 shares at an average of $2.20, traded Sep 29, 2026, filed Oct 1, 2026.

Conviction score
38
Value
$55k
25,007 shares
Holdings after
241,365
+12% from before
From 52-week low
+11%
low $1.94, close $2.16
From 52-week high
-81%
high $11.26, as of Sep 29, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $55k at market
    +7
  • Relative to holdings
    Holdings up 12%
    +3
  • Price context
    81% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    2 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

LPCNOct 9, 2026 · close 1.72
Since filing Oct 1, 2026: -16.9%SPY +1.9% · excess -18.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-26-045400, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2026POpen-market purchase
Common stock
+9,037$2.15$19k225,39512 d ago
Sep 30, 2026POpen-market purchase
Common stock
+15,970$2.23$36k241,36512 d ago

Related signals

Other insiders at Lipocine Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
41Moderate
LPCNbuy
Lipocine Inc.
John W. Higuchi
director
$27k
12,561 shares
+6%
61Notable
LPCNbuy 2
Lipocine Inc.
John W. Higuchi
director
$81k
40,000 shares
+24%
64Notable
LPCNbuy 2
Lipocine Inc.
John W. Higuchi
director
$252k
123,000 shares
+301%
66Notable
LPCNbuy 2
Lipocine Inc.
Mahesh V. Patel
Chief Executive Officer
$51k
25,000 shares
+18%
64Notable
LPCNbuy 2
Lipocine Inc.
Mahesh V. Patel
Chief Executive Officer
$51k
25,000 shares
+23%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John W. Higuchi bought $55k of LPCN | InsiderTell